Potential Mechanisms Linking SARS-CoV-2 to Autoimmunity
Immunoregulation · 18.07.2026 · 8 (1) · 0-0
DOI: 10.32598/immunoregulation.8.1 ↗Kurz gefasst
Fachartikel in der Zeitschrift Immunoregulation, online erschienen am 18.07.2026. Verfasst von Tooba Ghazanfar.
Abstract (Originalsprache)
Viral infections such as COVID-19 are significant environmental triggers for autoimmune diseases [1]. After infection with COVID-19, many autoimmune disorders that can potentially impact diverse organ systems may emerge [2]. The processes underlying the onset of autoimmunity in post-COVID-19 patients are complex and varied. Recent research has proposed several plausible mechanisms and theories to elucidate the molecular basis of immune dysregulation associated with COVID-19. These include molecular mimicry by viral proteins, systemic manifestations and multiorgan involvement due to the extensive expression of the SARS-CoV-2 receptor ACE2, bystander activation of immune cells, the release of autoantigens from virus-damaged tissues, superantigen-mediated lymphocyte activation, and epitope spreading. Several host factors, including age, comorbidities, and genetic predispositions, may also play a role [3].
Zitieren
APA
Ghazanfar, T. (2026). Potential Mechanisms Linking SARS-CoV-2 to Autoimmunity. Immunoregulation, 8(1), 0-0. https://doi.org/10.32598/immunoregulation.8.1
Vancouver
Ghazanfar T. Potential Mechanisms Linking SARS-CoV-2 to Autoimmunity. Immunoregulation. 2026;8(1):0-0. doi:10.32598/immunoregulation.8.1
BibTeX
@article{Ghazanfar2026,
author = {Ghazanfar, Tooba},
title = {Potential Mechanisms Linking SARS-CoV-2 to Autoimmunity},
journal = {Immunoregulation},
year = {2026},
volume = {8},
number = {1},
pages = {0--0},
doi = {10.32598/immunoregulation.8.1}
}
EUVIMED